Hematologic cancer resources gathered from across the web including a news brief, patient education, clinical trials and CME/CE
It’s a question that people frequently ask patients with cancer: ”What can I do to help?” The Leukemia & Lymphoma Society (LLS) has decided to answer that question through collaboration with Lotsa Helping Hands, a group that uses the Internet to build communities of volunteer caregivers.
The society offers a page on its Website where family, friends, and colleagues can create a community of helpers for a particular patient. The idea is to make the main caregiver’s job more manageable by using a private online calendar to organize the delivery of meals, rides to appointments, and other daily tasks. “Lotsa Helping Hands is a wonderful resource. It is an important partnership for LLS because we are committed to helping families manage the disruption of their living needs when a loved one has blood cancer,” said Hildy Dillon, LLS senior vice president of patient services, in a press release.
For patients with lower-than-normal levels of neutrophils, a special diet may be necessary. The neutropenic diet is designed to help protect a patient from bacteria and harmful organisms sometimes found in food and drinks. Under the “Managing Your Cancer” tab on the Leukemia & Lymphoma Society’s Website, patients can access basic guidelines and tips for staying healthy during treatment. This diet in particular advises patients to avoid uncooked vegetables, rare or raw meat, eggs and fish, soft mold-ripened cheeses, and well water. It suggests consuming only thoroughly cooked meats, pasteurized dairy products, tap water, and vacuum-packed lunchmeats.
STUDY TYPE: Interventional
AGE/SEX REQUIREMENTS: ≥18 years (None)
SPONSOR: Cancer and Leukemia Group B, National Cancer Institute
CLINICALTRIALS.GOV INDENTIFIER: NCT00003861
PURPOSE: This study aims to use leukemia-specific markers in bone marrow specimens to evaluate the expression of novel genes or micro-RNAs implicated in disease pathogenesis and treatment response. The findings will be correlated with novel treatment approaches and other biological and clinical prognostic features. Investigators are seeking 450 trial participants over 5 years.
EXPIRED: March 17, 2012
The goal of this CME activity is to identify key challenges when treating patients with diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, or Waldenström macroglobulinemia in community practice. Participants also will learn the ways in which community practitioners can effectively apply the latest research data to optimize treatment of patients with these diseases.